Evidence map›Paper›PMID 35772669›Full record

ArticleNature2022

GTSF1 accelerates target RNA cleavage by PIWI-clade Argonaute proteins.

Amena Arif, Shannon Bailey, Natsuko Izumi, Todd A Anzelon, Deniz M Ozata, Cecilia Andersson, Ildar Gainetdinov, Ian J MacRae, Yukihide Tomari, Phillip D Zamore

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Abundant piRNA production mediated by theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Amena ArifDepartment of Biochemistry and Molecular Biotechnology Graduate Program, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-4902-5167
Shannon BaileyHoward Hughes Medical Institute and RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Natsuko IzumiLaboratory of RNA Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0065-9257
Todd A AnzelonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3612-1907
Deniz M OzataHoward Hughes Medical Institute and RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0001-5215-8684
Cecilia AnderssonHoward Hughes Medical Institute and RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Ildar GainetdinovHoward Hughes Medical Institute and RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-1719-043X
Ian J MacRaeDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5112-0294
Yukihide TomariLaboratory of RNA Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8442-0851
Phillip D ZamoreHoward Hughes Medical Institute and RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA. phillip.zamore@umassmed.edu.ORCID http://orcid.org/0000-0002-4505-9618
Howard Hughes Medical Institute · USScripps Research Institute · USThe University of Tokyo · JP

Funding

Structural and Mechanistic basis for RNA SilencingR35GM127090 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI IAN JOHN MACRAE · 2018 to 2026
$5.6M
Understanding the Mechanism of RNA InterferenceR37GM062862 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZAMORE, PHILLIP D · 2010 to 2019
$5.3M
Understanding the Evolution, Biology, and Molecular Mechanism of Argonaute ProteinsR35GM136275 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PHILLIP D ZAMORE · 2020 to 2026
$3.3M
NIGMS NIH HHS R35 GM127090NIGMS NIH HHS R35 GM136275NIGMS NIH HHS R37 GM062862
6 · The paper itself

Abstract

Argonaute proteins use nucleic acid guides to find and bind specific DNA or RNA target sequences. Argonaute proteins have diverse biological functions and many retain their ancestral endoribonuclease activity, cleaving the phosphodiester bond between target nucleotides t10 and t11. In animals, the PIWI proteins-a specialized class of Argonaute proteins-use 21-35 nucleotide PIWI-interacting RNAs (piRNAs) to direct transposon silencing, protect the germline genome, and regulate gene expression during gametogenesis

Indexed as

Argonaute ProteinsIntracellular Signaling Peptides and ProteinsRNA CleavageRNA, Small InterferingAnimalsBiocatalysisFemaleMaleMiceArgonaute ProteinsCue110 protein, mouseIntracellular Signaling Peptides and ProteinsRNA, Small Interfering

Identifiers

PMID35772669
PMCPMC9385479
OpenAlexW4283721041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.